Abstract
We propose to describe exposure–response relationship of an antiepileptic agent, using mixed hidden Markov modeling methodology, to reveal additional insights in the mode of the drug action which the novel approach offers. Daily seizure frequency data from six clinical studies including patients who received gabapentin were available for the analysis. In the model, seizure frequencies are governed by underlying unobserved disease activity states. Individual neighbouring states are dependent, like in reality and they exhibit their own dynamics with patients transitioning between low and high disease states, according to a set of transition probabilities. Our methodology enables estimation of unobserved disease dynamics and daily seizure frequencies in all disease states. Additional modes of drug action are achievable: gabapentin may influence both daily seizure frequencies and disease state dynamics. Gabapentin significantly reduced seizure frequencies in both disease activity states; however it did not significatively affect disease dynamics. Mixed hidden Markov modeling is able to mimic dynamics of seizure frequencies very well. It offers novel insights into understanding disease dynamics in epilepsy and gabapentin mode of action.
Similar content being viewed by others
References
Miller R et al (2003) Exposure–response analysis of pregabalin add-on treatment of patients with refractory partial seizures. Clin Pharmacol Ther 73(6):491–505
Snoeck E, Stockis A (2007) Dose–response population analysis of levetiracetam add-on treatment in refractory epileptic patients with partial onset seizures. Epilepsy Res 73(3):284–291
Trokoñiz IF, Plan E, Miller R, Karlsson MO (2009) Modelling overdispersion and Markovian features in count data. J Pharmacokinet Pharmacodyn 36(5):461–477
Durbin R, Eddy S, Krogh A, Mitchison G (1998) Biological sequences analysis. Cambridge University Press, Cambridge
Rabiner LR (1989) A tutorial on hidden Markov models and selected applications in speech recognition. Proc IEEE 77(2):257–286
Haussler D, Krogh A, Mian I (1994) A hidden Markov model that finds genes in E. coli DNA. Nucleic Acids Res 22(22):4768–4778
Altman RM (2007) Mixed hidden Markov models: an extension of the hidden Markov model to the longitudinal data setting. J Am Stat Assoc 102(477):201–210
Rijmen F, IP EH, Rapp S, Shaw EG (2008) Qualitative longitudinal analysis of symptoms in patients with primary and metastatic brain tumours. J R Stat Soc Ser A Stat Soc 171(3):739–753
Maruotti A, Rydn T (2009) A semiparametric approach to hidden Markov models under longitudinal observations. Stat Comput 19:381–393
The Monolix software, Monolix Users Guide. http://software.monolix.org.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Delattre, M., Savic, R.M., Miller, R. et al. Analysis of exposure–response of CI-945 in patients with epilepsy: application of novel mixed hidden Markov modeling methodology. J Pharmacokinet Pharmacodyn 39, 263–271 (2012). https://doi.org/10.1007/s10928-012-9248-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10928-012-9248-2